About Smilax Laboratories
Smilax Laboratories is a Healthcare company based in Hyderabad (India) founded in 2005 by Suryadevara Krishna. APIs, intermediates, and pellets are manufactured by Smilax Laboratories. Smilax Laboratories has raised $14.04 million across 3 funding rounds from investors including Mumbai Waste Management, TNWML and Ramky Finance And Investment. The company has 521 employees. Smilax Laboratories was last valued at $44.2 million in November 2017. Its Indian entity Smilax Laboratories Limited reported revenue of ₹207 Cr. Smilax Laboratories offers products and services including APIs, API Intermediates, Pellets and DC Granules, and CDMO and CMO Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its competitors include Laurus Labs, Symbiotec and Jubilant Pharma; 2 of its 3 listed competitors have raised funding.
Company details
Smilax Laboratories was established in 2005 in Hyderabad, India, within the pharmaceutical sector. Active pharmaceutical ingredients (APIs), chemical intermediates, and pellets are produced as core operations. The company is led by Suryadevara Krishna, serving as Founder and Managing Director, alongside Muralikrishna Suryadevara as Managing Director. Focus is placed on manufacturing processes tailored for pharmaceutical applications, with activities centered in India.
- Headquarters Hyderabad, India
- Employees 521
- Founders Suryadevara Krishna
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website smilaxlabs.com
- Social LinkedIn
- Legal Name Smilax Laboratories Limited
- Date of Incorporation 20 Oct, 2004
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹207 Cr
FY 2025 · -25% YoY
- Net Loss-₹3.41 Cr
FY 2025 · -2% margin
- EBITDA₹11.52 Cr
FY 2025 · 6% margin
- Total Equity Funding$14.04M (USD)
in 3 rounds
- Latest Funding Round$7.61M (USD), Series A
Nov 2017
- InvestorsMumbai Waste Management
& 10 more
- Employee Count521
Associated legal entities of Smilax Laboratories
Smilax Laboratories operates through Smilax Laboratories Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Smilax Laboratories Limited CIN U24230TG2004PLC044461 | Active | 20 Oct 2004 | Hyderabad, Telangana | ₹207 Cr | 521 | 6 | View details |
Products & Services of Smilax Laboratories
Smilax Laboratories offers a comprehensive portfolio of products and services, including APIs, API Intermediates, Pellets and DC Granules, and CDMO and CMO Services.
Manufactures active ingredients for global generic drugs market
Provides intermediates for pharmaceutical API production worldwide
Offers pellets and granules for drug delivery in generics
Delivers custom manufacturing for pharmaceutical companies globally
Funding Insights of Smilax Laboratories
Smilax Laboratories has successfully raised a total of $14.04M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $7.61 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.04M
- Total Rounds 3
- Last Round Series A — $7.61M
- First Round $2.07M
(Mar 2007)
- Investors Count 11
All 3 funding rounds of Smilax Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $7.61M | Series A | $44.2M | Mumbai Waste Management | |
| Dec 2009 | $4.36M | Series A | $8.4M | Adr Constructions | |
| Mar 2007 | $2.07M | Angel Round | $••••• | Dakshayani K |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2017 | $44.2M | •••••••• |
| Dec 2009 | $8.4M | •••••••• |
| Mar 2007 | $••••• | •••••••• |
Full valuation and stage history of Smilax Laboratories
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $44.2M (Nov 2017). 11 investors in total: 4 institutional and 7 angel.
Investors in Smilax Laboratories
Smilax Laboratories has secured backing from 11 investors, including institutional and angel investors. Prominent investors backing the company include Mumbai Waste Management, TNWML and Ramky Finance And Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialized in hazardous waste disposal, bio-medical management, and industrial services. | mumbaiwastemanagement.com | Raigad, India | ||
Offers hazardous waste treatment, disposal, and environmental consulting to industries. | 2019 | tnwml.com | Chennai, India | |
ADR Constructions is engaged in civil engineering and construction projects. | adrconstructions.in | |||
YR Y R Nagaraja | unknown_1264873586a44cb39 | |||
YN Y N Madhu Rani | unknown_581aa07291ab41699 | |||
MS Muralikrishna Suryadevara | unknown_604753b0959b471d8 | |||
VR Veera Raghavamma | unknown_d6fafd3caa7d4deb8 | |||
AR Ayodhya Rami Reddy | unknown_4c1699df43b54242a | |||
YN Y N Madhurani | unknown_369abe81dc9147678 |
Investor details for Smilax Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Smilax Laboratories Limited (Smilax Laboratories)
Smilax Laboratories Limited is the primary company behind Smilax Laboratories. The board of Smilax Laboratories Limited currently have 4 directors; the longest-serving is Suryadevara Murali Krishna, appointed in 2010. 19 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suryadevara Murali Krishna DIN 00218735 | Managing Director | 01 Mar 2010 | 16 yrs 8 mo | Smilax Laboratories Limited |
| Ramakrishna Reddy Munnamgi DIN 05142334 | Director | 25 Jun 2019 | 7 yrs 4 mo | Smilax Laboratories Limited |
| Surender Reddy Geedipalli DIN 09266782 | Director | 24 Sep 2021 | 5 yrs 1 mo | Smilax Laboratories Limited |
| Saibaba Reddy Eadala DIN 09266834 | Director | 24 Sep 2021 | 5 yrs 1 mo | Smilax Laboratories Limited |
People of Smilax Laboratories
2 people are tracked at Smilax Laboratories (2 in leadership); the tracked headcount is 521.
| Name | Role | Group |
|---|---|---|
| Founder & Managing Director | Leadership | |
Muralikrishna Suryadevara | Managing Director | Leadership |
Complete people profiles for Smilax Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Smilax Laboratories
Figures of Smilax Laboratories Limited, the primary company behind Smilax Laboratories, for FY 2025. Revenue was ₹207 Cr (-25% year on year). Net loss was -₹3.41 Cr (-2% margin). EBITDA was ₹11.52 Cr (6% margin). Revenue has grown at a compounded annual rate of +1% over three years and +1% over five years.
- ₹207 CrRevenue · FY 2025 · -25% YoY
- -₹3.41 CrNet loss · -2% margin
- ₹11.52 CrEBITDA · 6% margin
- ₹96.04 CrPaid-up capital
- 521Employees (provident fund records)
- +1%Revenue CAGR, 3 years
- +1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Smilax Laboratories Limited are on its company page.
Detailed financial statements for Smilax Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Smilax Laboratories
4 dated milestones of Smilax Laboratories across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Smilax Laboratories is founded.
- Funding First funding round of $2.1M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $7.6M.
Competitors of Smilax Laboratories
Smilax Laboratories has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and Jubilant Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| jubilantpharma.com | 1978 | Noida, India | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. |
Detailed competitors of Smilax Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Smilax Laboratories
The website of Smilax Laboratories (smilaxlabs.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▼ 9.7% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Smilax Laboratories (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Smilax Laboratories
Complete news archive for Smilax Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Smilax Laboratories
Smilax Laboratories was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Smilax Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Smilax Laboratories is a funded company, having raised a total of $14.04M across 3 funding rounds to date. The company's 1st funding round was a Angel Round of $2.07M, raised on Mar 2007.
Smilax Laboratories has 521 employees.
The primary company behind Smilax Laboratories, Smilax Laboratories Limited, reported revenue of ₹207 Cr for FY 2025, down 25% year on year.
Smilax Laboratories was established in 2005 in Hyderabad, India, within the pharmaceutical sector. Active pharmaceutical ingredients (APIs), chemical intermediates, and pellets are produced as core operations. The company is led by Suryadevara Krishna, serving as Founder and Managing Director, alongside Muralikrishna Suryadevara as Managing Director. Focus is placed on manufacturing processes tailored for pharmaceutical applications, with activities centered in India.
Smilax Laboratories's top competitors include Laurus Labs, Symbiotec and Jubilant Pharma.
Smilax Laboratories offers APIs, API Intermediates, Pellets and DC Granules, and CDMO and CMO Services.
Smilax Laboratories has 11 investors. Key investors include Mumbai Waste Management, TNWML, Ramky Finance And Investment, ADR Constructions, and Y R Nagaraja.
The valuation of Smilax Laboratories is $44.2M as of Nov 2017.
Smilax Laboratories operates through Smilax Laboratories Limited.
The legal entities of Smilax Laboratories currently have 6 directors, including Ramakrishna Reddy Munnamgi, Suryadevara Murali Krishna, Pulicherla Ganesh and others.